WEIGAO GROUP Buys Back 0.26 Million H-Shares, Lifts Treasury Stock to 71.29 Million

Bulletin Express11-19 17:40

Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a repurchase of 258,000 H-shares on 19 November 2026, adding the shares to treasury at a volume-weighted average price of HK$3.16 per share. The buyback represents 0.0058% of the company’s issued share capital (excluding treasury shares) prior to the transaction and involved a total cash outlay of HK$0.81 million.

Following the purchase, WEIGAO GROUP’s issued share count (excluding treasury shares) decreased to 4.45 billion, while treasury shares rose to 71.29 million. The overall issued share capital remains unchanged at 4.52 billion shares pending any future cancellations.

The transaction forms part of the HK$ repurchase mandate approved on 29 May 2026, which authorises the company to acquire up to 446.46 million shares. Cumulative buybacks under this mandate now total 13.96 million shares, equal to 3.13% of the issued share base at the mandate date.

In accordance with Hong Kong Stock Exchange rules, WEIGAO GROUP is subject to a moratorium on new share issues or sales/transfers of treasury shares until 20 December 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment